An end to the Iran conflict should rally stocks — but only briefly
Private-credit cracks, high stock valuations and shaky IPO prospects will curb investors’ enthusiasm.
Real-time market intelligence across asset classes
Chart context, AI evidence, sentiment, related news, and verified outcome history are grouped into one asset dossier.
| Insider | Role | Date | Type | Value |
|---|---|---|---|---|
| LILLY ENDOWMENT, INC. | Shareholder | Jul 07 '26 | Proposed Sale | 372018600.0 |
| LILLY ENDOWMENT, INC. | Shareholder | Jun 26 '26 | Proposed Sale | 343945450.0 |
| Yuffa Ilya | EVP&Pres, LLY … | Jun 10 '26 | Sale | 2876925.0 |
| Yuffa Ilya | Officer | Jun 10 '26 | Proposed Sale | 2876925.0 |
| LILLY ENDOWMENT, INC. | Shareholder | May 28 '26 | Proposed Sale | 335705200.0 |
| LILLY ENDOWMENT, INC. | Shareholder | May 22 '26 | Proposed Sale | 312495000.0 |
| LILLY ENDOWMENT, INC. | Shareholder | May 20 '26 | Proposed Sale | 311530050.0 |
| LILLY ENDOWMENT INC | Former 10% … | May 06 '26 | Sale | 15754537.0 |
| LILLY ENDOWMENT, INC. | Shareholder | May 06 '26 | Proposed Sale | 296661000.0 |
| Zakrowski Donald A | SVP, Finance, … | Feb 16 '26 | Option Exercise | 0.0 |
Source: FinViz — Data may be delayed
AI-curated news influencing LLY price, sentiment, and trend
Private-credit cracks, high stock valuations and shaky IPO prospects will curb investors’ enthusiasm.
Eli Lilly & Co. shares dip after HSBC turned bearish on the stock, for the second time in a year, …
Eli Lilly's stock is a bit expensive, even with a bit of a decline this year.
Eli Lilly has recently trailed the S&P 500 Index, though analysts remain confident in its longer-term trajectory.
Eli Lilly shares rose after the Mounjaro maker said it had agreed to acquire biotechnology company Orna Therapeutics for $2.4 …
More Big Tech earnings are ahead from Amazon and Alphabet.
Multi-Provider AI Analysis